scholarly journals THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT

2020 ◽  
Author(s):  
Ferrara F ◽  
De Rosa F ◽  
Pelliccia C ◽  
La Porta R ◽  
Vitiello A
Keyword(s):  
Peer Review ◽  
Current Evidence ◽  
Medical Sciences ◽  
Global Pandemic ◽  
Complex Patients ◽  
Initial Stage ◽  
Unique System ◽  
Lung Injuries ◽  
Review Reports ◽  
E Mail

The new Sars-Cov-2 (COVID-19) is causing thousands of deaths worldwide and has caused a global pandemic, one of the biggest health challenges ever faced in history. in the most severe cases, Sars-Cov-2 infection can cause fatal lung injuries. In this context, it is essential to recognise effective therapeutic agents against the virus. There are currently no direct and effective vaccines and antivirals available. People with pre-existing conditions, such as diabetes, and with chronic drug therapies in place may represent complex patients difficult to manage clinically during COVID-19 infection and at high risk of major complications. The regulation of blood glucose and the adoption of appropriate measures are critical aspects to consider for the diabetic patient in this pandemic period, especially in the patient with ongoing infection. In this article we describe the current evidence in the literature on the possible risks of side effects caused by taking antidiabetic drugs in the COVID-19 patient and the data on extra homeostasis glycemic activity useful to fight viral infection. Peer Review History: Received 25 May 2020; Revised 8 June; Accepted 3 July, Available online 15 July 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Heba M. Abd El-Azim Affiliation: Damanhour University, Egypt E-mail: [email protected]   Name: Dr. George Zhu  Affiliation: Tehran University of Medical Sciences, Tehran, Iran E-mail: [email protected]   Comments of reviewer(s): Similar Articles: THE RELATIONSHIP BETWEEN DIABETES MELLITUS AND TUBERCULOSIS IN REVIEW OF PREVALENCE, DIAGNOSTICS AND PREVENTION

scholarly journals AWARENESS OF PHARMACISTS TOWARDS ASPARTAME SIDE EFFECTS IN KHARTOUM CITY, SUDAN

2020 ◽  
Author(s):  
Musab Hassan Dafaalla ◽  
Ahmed Mustafa Khidir ◽  
Eiman Abubakr Osman ◽  
Ali Awadallah Saeed ◽  
Mohamed A. Mousnad
Keyword(s):  
Side Effects ◽  
Peer Review ◽  
Attention Deficit Disorder ◽  
Community Pharmacists ◽  
High Energy ◽  
Artificial Sweetener ◽  
Initial Stage ◽  
Unique System ◽  
Review Reports ◽  
E Mail

Objective:  Aspartame (or APM) is the name for an artificial, non-saccharide sweetener used as a sugar substitute in many foods and beverages. Aspartame is the methyl ester of a phenylalanine/aspartic acid dipeptide. Aspartame is an artificial sweetener. It is 200 times sweeter than sugar in typical concentrations, without the high-energy value of sugar. Aim of current study was to study the awareness of pharmacists about aspartame side effects. Materials and methods: This study was carried in greater Khartoum, questionnaire for pharmacists to see the consumption and the awareness of them to these interactions during the period from September 2014 to November 2014.Study was conducted among practicing pharmacists. A pre designed and tested questionnaire were used for each category to collect the data. From the hospitals manager. Results: 32% were aware of the number of aspartame products. Pharmacists when asked how many patients purchase aspartame products per day, answers showed that 74.5% ranged between 1-10 patients per day, About pharmacist’s expectations to develop side effects due to aspartame, use regularly showed that 75% agreed that it would. pharmacists claimed that aspartame can or worsen a certain list of some diseases in which that diabetes represented 30%, Alzheimer’s 28% , attention deficit disorder 17.3% , psychological disorders. Conclusion: The majority of community pharmacists expect side effects can be developed due to aspartame regular use by patients but majority didn’t know what are the exact side effects and the exact diseases that can be worsened when using aspartame. Peer Review History: Received 11 June 2020; Revised 28 June; Accepted 3 July, Available online 15 July 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Prof. Dr. Hassan A.H. Al-Shamahy Affiliation: Sana'a University, Yemen E-mail: [email protected]   Name: Dr. Nada Farrag Affiliation: Misr International University Egypt E-mail: [email protected]   Comments of reviewer(s): Similar Articles: AWARENESS AMONGST YOUTH ABOUT USE AND ABUSE OF STEROIDS IN KARACHI, PAKISTAN

scholarly journals COSMETOTEXTILES AND EVALUATION OF THEIR PERFORMANCE

2021 ◽  
Author(s):  
Evren ALGIN YAPAR ◽  
İmren ESENTÜRK ◽  
Aslı ŞAHİNER ◽  
Ece HALAT ◽  
Bilge Ahsen KARA ◽  
...  
Keyword(s):  
Peer Review ◽  
Woven Fabrics ◽  
Woven Fabric ◽  
Medical Sciences ◽  
Initial Stage ◽  
Unique System ◽  
Standards And Regulations ◽  
Outer Appearance ◽  
Review Reports

Cosmetotextiles are textile products that release a cosmetic substance or formulation in the application area for cosmetic purposes. Cosmetic substances or formulations loaded carriers such as micro or nano-sized microcapsules, microsphere, cyclodextrin, liposome, solid lipid nanoparticles, are attached or processed on textile to prepare cosmetotextiles. As a textile material woven fabric, knitted fabric and non-woven fabrics are used for cosmetotextiles, and within this scope, relevant cosmetic and textile standards and regulations are taken into account in the performance evaluation of products, especially for effectiveness and safety. Important standards for cosmetotextiles include PD CEN/TR 15917:2009, ISO 3175-1, ISO 3758, ISO 6330 and ISO 22716. PD CEN/TR 15917:2009 includes the tests for cosmetic claim substation such as skin moisturizing, body firming, assessment of outer appearance of cellulite etc. The PD CEN/TR 15917:2009 standard specifies the general properties, claimed effects, safety assessment and labeling of slimming, moisturizing and regenerating preparations that fall into the cosmetotextile class.                   Peer Review History: Received: 13 May 2021; Revised: 19 June; Accepted: 29 June, Available online: 15 July 2021 Academic Editor: Dr. Asia Selman Abdullah,  Al-Razi university, Department of Pharmacy, Yemen, [email protected] UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.  Received file:                Reviewer's Comments: Average Peer review marks at initial stage: 6.0/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, [email protected] Dr. Mohamed Salama, Modern University for Technology & Information, Egypt, [email protected]  

scholarly journals A STUDY OF PHYTOCHEMICAL CONSTITUENTS IN CARALLUMA QUADRANGULA

2020 ◽  
Author(s):  
Jamal A. N. Al-Mahweety ◽  
Sadeq HS Azzam ◽  
Ali Alyahawi
Keyword(s):  
Peer Review ◽  
Folk Medicine ◽  
Chemical Components ◽  
Phytochemical Analysis ◽  
Medicinal Uses ◽  
Initial Stage ◽  
Unique System ◽  
Review Reports ◽  
First Time ◽  
E Mail

Objectives:  Caralluma belongs to the family Asclepiadaceae, native to the Indian sub-continent have different medicinal properties and used in folk medicine as remedies to treat wide variety of diseases and health conditions. Objective of present study was to isolate, analyze and identify the phytochemicals composition from steam of Caralluma  quadrangula. Methods:  Extractions of the chemical components was carried out by different chromatographic techniques. The phytochemical characterizations were evaluated by nuclear magnetic resonance and mass spectrometry. Results:  The quantitative phytochemical analysis of this species exhibited the presence of three compounds, Glochidonol (5gm), Dihydroxy-14-pregn-5-en-20-one (9.8gm), Hydroxystigmast-5-en-7-one (7.8gm) and Stigmasterol (5.7 mg). Hydroxystigmast-5-en-7-one, report from Caralluma  quadrangula stem as first time.     Conclusion:  The present study is strengthen for the discovery three pure chemical compounds from C. quadrangula. Peer Review History: Received 2 April 2019; Revised 22 April; Accepted 7 May, Available online 15 May 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 4.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Ahmad Najib Affiliation: Universitas Muslim Indonesia, Makassar, Indonesia E-mail: [email protected]   Name: Dr. Hatem Sameir Abbas Affiliation: Al-Azhar University, Egypt E-mail: [email protected] Comments of reviewer(s): Similar Articles: A REVIEW ON CONSTITUENTS, PHARMACOLOGICAL ACTIVITIES AND MEDICINAL USES OF GLYCYRRHIZA GLABRA MURRAYA KOENIGI-A BOON IN DIFFERENT PATHOLOGICAL CONDITIONS

scholarly journals PHYTOCHEMICAL PURIFICATION OF ACTIVE CONSTITUENTS ISOLATED FROM ROOT OF THE MEDICINAL HERB, CARALLUMA QUADRANGULA

2020 ◽  
Author(s):  
Jamal AN. Al-Mahweety ◽  
Ammer Al-Fadaly ◽  
Waled Abdo Ahmed
Keyword(s):  
Peer Review ◽  
Folk Medicine ◽  
Phytochemical Analysis ◽  
Initial Stage ◽  
Unique System ◽  
Pure Compounds ◽  
Phytochemical Compounds ◽  
Review Reports ◽  
E Mail

Objective: Present study aim for the purification of quantitative phytochemical compounds from roots of  Caralluma quadrangula belongs to the family Asclepiadaceae. This type of plants can be use as folk medicine  to take care of wide diversity of health  and diseases situation. Methods: Preliminary phytochemical analysis for different type of chemical compounds by using various  chromatographic techniques. The phytochemical characterizations were evaluated by nuclear magnetic resonance and mass spectrometry. Results: The quantitative phytochemical analysis of this species exhibited the presence four pure compounds,  hydroxyoplopan-4-one (4.5 mg), dihydroxyeudesm-4(15)-ene (5.0 mg), and quercetin- rhamnopyranosyl-D-glucopyranose (Rutin) (7.0 mg). Conclusion: From this study, it can be concluded that the species found four pure compounds from C. quadrangula. Peer Review History: Received 25 July 2020; Revised 10 August; Accepted 28 August, Available online 15 September 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.0/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Name: Marwa  A. A. Fayed Affiliation: Faculty of Pharmacy, University of Sadat City, Egypt E-mail: [email protected]   Name: Dr. Ali Gamal Ahmed Al-kaf Affiliation: Sana'a university, Yemen E-mail: [email protected]   Name: Ahmad Najib Affiliation: Department of Pharmacognosy-Phytochemystry Universitas Muslim Indonesia-Indonesia E-mail: [email protected]   Comments of reviewer(s): Similar Articles: A STUDY OF PHYTOCHEMICAL CONSTITUENTS IN CARALLUMA QUADRANGULA PHARMACOGNOSTIC EVALUATION OF GOMPHRENA SERRATA ROOT

scholarly journals INFLAMMATORY BOWEL DISEASE: CLINICAL FEATURES AND MANIFESTATIONS BEYOND THE BOWEL

2020 ◽  
Author(s):  
Maged Almezgagi ◽  
Yu Zhang ◽  
Fadhl Al-shaebi ◽  
Mueataz A. Mahyoub ◽  
ALariqi Reem ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Peer Review ◽  
Bowel Disease ◽  
Medical College ◽  
National Medical ◽  
Initial Stage ◽  
Unique System ◽  
Inflammatory Bowel ◽  
Review Reports ◽  
E Mail

Inflammatory bowel disease (IBD) encompasses a spectrum of diseases, with Crohn's disease (CD) and ulcerative colitis (UC) representing the two broadest subtypes of IBD. Multiple extraintestinal manifestations (EIMs) are more frequent in (IBD); 5% –50% of the patients might be affected. The most often implicated sites of manifestations are musculoskeletal and dermatological structures. However, while some symptoms like peripheral arthritis and erythema nodosum correlate with IBD progression, others have their own course of disease like axial arthropathy, gangrenosis of the pioderma and primary sclerosic cholangitis. This review would provide a summary of the most frequent EIMs and their prevalence. Peer Review History: Received 31 May 2020; Revised 7 June; Accepted 4 July, Available online 15 July 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Md. Parwez Ahmad Affiliation: National Medical College, Birgunj, Nepal E-mail: [email protected]   Name: Dr. George Zhu  Affiliation: Tehran University of Medical Sciences, Tehran, Iran E-mail: [email protected]   Comments of reviewer(s):  

scholarly journals AN OVERVIEW ON PHARMACOPOEIAS IN THE WORLD AND MONOGRAPH ELABORATION TECHNIQUES

2020 ◽  
Author(s):  
Evren ALGIN YAPAR ◽  
Mehmet Emre ÖZDEMİRHAN
Keyword(s):  
Peer Review ◽  
World Health ◽  
Initial Stage ◽  
Unique System ◽  
The World ◽  
Review Reports ◽  
Health Organization ◽  
Pharmaceutical Production ◽  
Official Sources ◽  
E Mail

Pharmacopoeias are official sources that contain national and international rules that must be complied with legally and scientifically regarding substances, materials, drugs, devices and methods used in pharmaceutical field and pharmaceutical production. The monographs are consisted of general titles such as definition, production, characters, identification, tests, assay, storage, labelling and impurities. The World Health Organization states that sixtyeight different pharmacopoeia continue to be used effectively in fifty six countries around the world. In this review information about national and international wold pharmacopoeias, structure and general content of pharmacopoeias, and monograph elaboration techniques are given. Peer Review History: Received 26 April 2020; Revised 25 May; Accepted 3 July, Available online 15 July 2020 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 6.0/10 Average Peer review marks at publication stage: 8.0/10 Reviewer(s) detail: Name: Dr. Mohammed Abdel-Wahab Sayed Abourehab Affiliation: Umm Al-Qura University;  Makkah Al-Mukarramah, Saudi Arabia E-mail: [email protected]   Name: Heba M. Abd-El-Azim Affiliation: Faculty of Pharmacy – Damanhour University E-mail: [email protected]   Comments of reviewer(s):  

scholarly journals DIABETOGENIC EFFECT OF STATINS: MOLECULAR MECHANISMS

2021 ◽  
Author(s):  
Nuray Arı
Keyword(s):  
Peer Review ◽  
Molecular Mechanisms ◽  
Diabetic Rats ◽  
Pharmaceutical Chemistry ◽  
Acorus Calamus ◽  
Medical Sciences ◽  
Initial Stage ◽  
Unique System ◽  
Review Reports

Statins, HMG CoA inhibitors, are potent hypolipidemic drugs.They are used for the prevention of cardiovascular diseases and some of the most commonly used drugs worldwide. Long term statin therapy can cause a modest increase in new-onset diabetes risk, and there is great interest in the mechanisms for this adverse effect. Main proposed mechanisms are increased insulin resistance and some defects in insulin secretion. Many factors can affect the risk including pre-existing diabetic risk, older age and potency of statin. But clearly, the benefits of these drugs in preventing cardiovascular disease outweigh the potential risk of diabetes.The aim of this review is to give underlying pathomechanisms and clinical relevance of diabetogenic effect of statins.                     Peer Review History: Received: 18 May 2021; Revised: 24 June; Accepted: 29 June, Available online: 15 July 2021 Academic Editor: Dr. Ali Abdullah Al-yahawi, Al-Razi university, Department of Pharmacy, Yemen, [email protected] UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.  Received file:                Reviewer's Comments: Average Peer review marks at initial stage: 5.0/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. Salfarina Ramli, Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia. [email protected]       Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, [email protected]  Similar Articles: EFFECTS OF EMODIN ON BLOOD GLUCOSE AND BODY WEIGHT IN TYPE 1 DIABETIC RATS ACORUS CALAMUS L ON TYPE 2 DIABETES MELLITUS MEDICATION

scholarly journals ETHNOBOTANY, PHYTOCHEMISTRY AND PHARMACOLOGY OF OCHNA SCHWEINFURTHIANA: A REVIEW

2020 ◽  
Author(s):  
Yusuf AJ ◽  
Abdullahi MI ◽  
Muhammad AA
Keyword(s):  
Peer Review ◽  
Wide Spectrum ◽  
Ethanol Extract ◽  
Traditional Healers ◽  
Diabetic Rats ◽  
Initial Stage ◽  
Unique System ◽  
Biological Studies ◽  
Review Reports ◽  
E Mail

Ochna schweinfurthiana (Os, Family: Ochnaceae) is a small evergreen tree used in ethnomedicine to treat different ailments; it is also used in agri-horticulture and as ornaments, dyes among others. It is a rich source of complex dimers of flavonoids and used for treatment of pain, inflammation, and arthritis. Chemical investigations carried out on the different parts of the plant have been confined to phenolic compounds majorly, bioflavonoids, glycosides, steroids and terpenes. The plant, O. schweinfurthiana have shown a wide spectrum of biological and pharmacological properties which include antimicrobial, cytotoxic/antiproliferative, genotoxicity, antinociceptive, anti-inflammatory, antioxidant and antiplasmodial.  This review comprehensively summarizes the potential effects of the plant O. schweinfurthiana, chemically and pharmacologically. However, more researches in the aspect of phytochemical and biological studies are needed to exhaustively isolate bioactive compounds and evaluate their effects on other ailments as claimed by the traditional healers. Peer Review History: UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Name: Dr. Mohamed Derbali    Affiliation: Faculty of Pharmacy, Monastir, Tunisia. E-mail: [email protected]   Name: Ahmad Najib Affiliation: Universitas Muslim Indonesia, Makassar, Indonesia E-mail: [email protected] Comments of reviewer(s): Similar Articles: ANTIHYPERGLYCEMIC AND ANTI-OXIDANT POTENTIAL OF ETHANOL EXTRACT OF VITEX THYRSIFLORA LEAVES ON DIABETIC RATS

scholarly journals COVID-19: CURRENT PHARMACOLOGICAL THERAPEUTIC APPROACHES

2021 ◽  
Author(s):  
Mai ES. Ghoneim ◽  
Asmaa A. Khalifa ◽  
Bassma M. Ali
Keyword(s):  
Peer Review ◽  
Treatment Strategies ◽  
Medical Sciences ◽  
Initial Stage ◽  
Unique System ◽  
The World ◽  
Repurposed Drugs ◽  
Review Reports

By the end of 2019, SARS-CoV-2, a new virus from Coronaviruses family,  has been detected in China and was responsible for COVID-19 disease.  This disease has been suddenly and vigorously disseminated among individuals all over the world. Based on genetic vicinity, this novel virus is similar to SARS-CoV and MERS-CoV; it can spread from an unknown animal host to individuals. Till now, there is no specific therapy or vaccine for the treatment of COVID-19 patients. However, published clinical data and in vitro studies may offer treatment strategies of some effective antiviral and repurposed drugs, including remdesivir, favipiravir, lopinavir/ritonavir, corticosteroids, etc. This narrative review describes current pharmacological proposed treatments for COVID-19 patients and available experimental and clinical studies for these drugs. Eventually, these data may help to explain the most preferable way to treat COVID-19 and lessen symptoms and complications accompanied with it.                                 Peer Review History: Received 6 November  2020; Revised 25 Decembe; Accepted 4 January, Available online 15 January 2021 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file:                           Comments of reviewer(s):         Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, [email protected] Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, [email protected] Dr. Nuray Arı, Ankara University, Turkiye, [email protected] Similar Articles: USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2 THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT EUCALYPTUS ESSENTIAL OIL; AN OFF-LABEL USE TO PROTECT THE WORLD FROM COVID-19 PANDEMIC: REVIEW-BASED HYPOTHESES SUDANESE EXPERIENCE OF HERBAL FORMULAS USED DURING COVID-19 INFECTION TRADITIONAL TO RECENT APPROACHES IN HERBAL MEDICINE THERAPY OF COVID-19  

scholarly journals AN OVERVIEW ON CURRENT REGULATION AND EVALUATION OF BIOCIDAL PRODUCTS

2019 ◽  
Author(s):  
Aslı ŞAHİNER ◽  
Evren ALGIN YAPAR
Keyword(s):  
Peer Review ◽  
Chemical Substance ◽  
Biological Action ◽  
Insect Repellents ◽  
Biocidal Products ◽  
Unique System ◽  
Natural Oil ◽  
Review Reports ◽  
E Mail ◽  
Biocidal Product

A biocidal product is a substance or mixture prepared to limit, destroy, neutralize or control the effects of a harmful microorganism, plants and animals. The active substance in a biocidal product can be a natural oil or extract, a chemical substance or a microorganism, virus or fungus. Biocides consist of four main groups: disinfectants, preservatives (wood, paint, etc.), pest control and other type of biocidal products. A biocidal substance can also be added to a product to make the product itself into a biocidal product. These products range from disinfectants, hand sanitizers, preservatives, insect repellents, to rodenticides and insecticides and are used to protect humans, animals, materials and articles by controlling the intended target organism by a chemical or biological action. To make sure the use of biocidal products do not have unacceptable risks for people, animals and the environment, they are regulated to control their marketing, sale and use. In the current study biocidal products have been overviewed in the scope of current European Union regulations, product types and conformity tests. Peer Review History: UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file Average Peer review marks at initial stage: 5.0/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Name: Dr. Barkat Ali Khan Affiliation: Kampala International University , Uganda E-mail: [email protected]   Name: Dr. Sally A. El-Zahaby Affiliation: Pharos University in Alexandria, Egypt E-mail: [email protected] Comments of reviewer(s):

Sign in / Sign up

Export Citation Format

Share Document